Strategic Partnerships Artinis has a pattern of strategic collaborations and acquisitions (Gilde Healthcare acquisition issued Sep 2025; partnerships with NIRx Medical Technologies and iMotions in 2025). This indicates openness to OEM and integration partnerships, suggesting sales opportunities around co-development, distribution agreements, and bundled solutions with complementary technologies.

Product Expansion Recent launch of Brite MKIV (Dec 2025) signals ongoing product development and a push to expand fNIRS capabilities across settings. Sales opportunities exist in upselling upgraded hardware, software features, and new accessories to existing customers and in converting competitors’ users to Artinis solutions.

Academic Focus Longstanding collaboration with universities and research institutions (Radboud University partnership noted) positions Artinis as a preferred supplier for research-grade fNIRS equipment. This suggests targeting academic labs, grant-funded projects, and contract research organizations as primary segments.

Quality and Compliance ISO 13485:2016 certification underscores a commitment to quality management for medical devices. This can be leveraged in conversations with hospitals, clinics, and QA-sensitive buyers to differentiate Artinis as a reliable supplier for quality assurance equipment and regulated environments.

Global Reach, Niche Focus Small-to-mid-size team (51-200 employees) with a global footprint through university and industry partnerships indicates agility and specialized expertise in fNIRS. Leverage this positioning to pursue targeted regional expansions, channel partnerships, and turnkey solutions for neuroimaging and radiological QA markets alongside larger insurers or distributors.